Abstract. Our expression signatures of human cancers including head and neck squamous cell carcinoma (HNSCC) demonstrated that downregulation of microRNA-133a (miR133a) were frequently observed in cancer cells. The restoration of miR-133a in cancer cells revealed that it functions as a tumor suppressor. In this study, we investigated the novel molecular targets of miR-133a in HNSCC cancer cells and its oncogenic function, especially as it contributes to cancer cell migration and invasion. The genome-wide gene expression analysis and bioinformatics study showed that actin-related protein 2/3 complex subunit 5 (ARPC5) is a candidate target of miR-133a. Furthermore, luciferase reporter assay demonstrated that ARPC5 is directly regulated by miR-133a. Silencing of ARPC5 revealed significant inhibition of cell migration and invasion in HNSCC cell lines, SAS, HSC3 and IMC-3. In HSC3 cells, restoration of miR-133a or silencing ARPC5 led to a reorganization of the actin cytoskeleton and a subsequent change in cell morphology to a round, bleb-like shape. The expression levels of ARPC5 were significantly higher in HNSCC tissues than in noncancer tissues. Immunohistochemistry showed that the levels of ARPC5 expression were significantly higher in invasive cancer cells. ARPC5 contributed to cancer cell migration and invasion in HNSCC and this gene was directly regulated by miR-133a. Our analysis of novel tumor-suppressive miR-133a-mediated cancer pathways provides new insights into the potential mechanisms of HNSCC oncogenesis.
IntroductionHead and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer in the world and about 500,000 cases occur every year (1). In spite of considerable advances in multimodality therapy, including surgery, radiotherapy and chemotherapy, the overall five-year survival rate for patients with HNSCC is only 40-50% (2). The poor prognosis is caused by metastasis and recurrence of the cancer. A deeper understanding of these problems is important to achieve further improvements in treatment of the disease. microRNAs (miRNAs) are small non-coding RNAs 20-22 nucleotides in length. They are involved in crucial biological processes, including development, differentiation, apoptosis and proliferation through imperfect pairing with target messenger RNAs (mRNAs) of protein-coding genes and transcriptional or post-transcriptional regulation of their expression. Bioinformatic predictions indicate that miRNAs regulate more than 30% of the protein coding genes (3). Currently, 1527 human miRNAs are registered at miRBase release 18.0 [http:// microrna.sanger.ac.uk/]. miRNAs are aberrantly expressed in many human cancers and can function either as tumor suppressors or oncogenes (4). In cancer pathways, normal regulatory mechanisms are disrupted by aberrant expression of tumor suppressive or oncogenic miRNAs.Our recent studies demonstrated that downregulation of miR-133a occurred frequently in various cancers, including HNSCC (5-7). In fact, miR-133a appeared to function as a tumor suppressor. Restora...